Effects of upper respiratory tract infections in patients with cystic fibrosis.
about
Vaccines for preventing influenza in people with cystic fibrosisVaccines for preventing influenza in people with cystic fibrosisDigging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic FibrosisPopulation structure and evolution of RhinovirusesImmune Responses in Rhinovirus-Induced Asthma Exacerbations.The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosisPathogenesis of rhinovirus infection.In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.The changing microbial epidemiology in cystic fibrosis.Vaccines for preventing influenza in people with cystic fibrosis.Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.Antiviral therapy for enteroviruses and rhinoviruses.Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection.Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosisClinical significance of microbial infection and adaptation in cystic fibrosis.The airway epithelium: soldier in the fight against respiratory virusesRole of picornaviruses in flu-like illnesses of adults enrolled in an oseltamivir treatment study who had no evidence of influenza virus infection.Impact of respiratory viral infections on cystic fibrosis.Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onsetPseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cellsRhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.Rhinovirus infections and adenoidal hypertrophy: do they interact with atopy in children?Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.Cystic fibrosis and the war for iron at the host-pathogen battlefrontCystic fibrosis: a polymicrobial infectious disease.Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings.Home Self-Collection of Nasal Swabs for Diagnosis of Acute Respiratory Virus Infections in Children With Cystic Fibrosis.Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity.Ten years of viral and non-bacterial serology in adults with cystic fibrosis.Rhinovirus-Induced Exacerbations of Asthma and COPD.Human rhinoviruses and severe respiratory infections: is it possible to identify at-risk patients early?Spectrum of viral infections in patients with cystic fibrosis.Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.The diagnosis and management of respiratory viral infections in cystic fibrosis.Respiratory Viral Infections in Chronic Lung Diseases.Viruses in cystic fibrosis patients' airways.The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model.RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells.Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
P2860
Q24198036-F7E0A0F4-501F-44F3-9FAC-8EE218CCC879Q24240244-8AEFF620-DB0E-4E4E-A134-774E781B19C9Q28078583-263DE171-DC26-494E-8240-E418298F310CQ28539894-BF37A595-065F-4FB2-BFB0-C6E39CD958D3Q30275562-72494FC1-4DD4-418D-8CC2-5DBFEDF7AD4EQ30385981-735687EC-A376-46B9-8C52-E6E175BED8A9Q30419010-D609E531-3C58-4EF8-BACA-8D4DAD95CF6EQ30443266-A0A3B562-E846-4617-BEBE-77961E3641AFQ30448335-AF4B3995-A0B0-499D-905A-7259DE3C8709Q33825634-DA01929D-87D0-4FCC-BDB5-D353403C229CQ33909908-105C63B8-EA59-40D9-83F1-F98452CD1DC8Q33916434-CF38DFDB-8BB3-4450-9CE2-0E6758395692Q34009823-A6425A57-2623-4BF3-AF98-A153E07962FDQ34017296-C72FDFC3-9203-4306-A512-725B908B7876Q34479158-D9A16DC8-E9A2-495E-8BEF-400168F4A1BEQ34491552-64A5FCD4-D220-4B80-8E15-404C8E3DC702Q34491598-328A106E-74EC-45BA-9FD9-B5EEFD8B8765Q34942946-5FDD30A0-A607-479A-83E6-81C750A1BDEBQ35125997-4FD75676-E521-4FD5-8D53-38DF34CEE959Q35143420-49DA89B9-CBE8-4220-BAA0-E0E92CBE7F56Q35272861-61045E5F-2FB2-4589-98CE-A9D67EFCE7D2Q35524948-4FB1A21B-E524-4800-91EC-F423FE44D7E9Q35917190-BFCEF9D2-1437-4EB5-91AC-2821E760ACBEQ36598940-554CB2E1-6C7E-483D-8FD3-981FEF5DF344Q36598958-0B5D3673-73F7-4D58-BA1E-FB6378F377BDQ36895733-6FD3D19B-C53D-42F6-B21E-87FC244BCDDAQ37085436-30EB9B2F-4C42-4D33-AF9B-C99DE26D9DD7Q37406746-D9C16E89-D389-4F78-9D50-477ED0640DD4Q37705435-69C992B8-03F8-4E5F-BC78-9D36CC84A8F1Q37860254-649FFBF8-69BB-4BDB-A2B0-291A530C52CFQ38166378-408693D6-A2A9-4827-B93D-461B1960FBCAQ38190110-2BD1272E-C6E1-484C-8786-D381DE732421Q38201055-590FF092-CABB-4BF8-94B0-AA4E6634A5FEQ38945689-CCAB94B5-D229-441C-991F-DD64BB860E5FQ39108263-3AD64489-9701-44EA-9931-3E434A5B2CB1Q39118441-E49C8162-4BE4-446F-9B99-31E9AE1927CBQ39199043-0595A4F1-CEFE-4852-A800-F053DC94C00EQ39262123-8D758D47-81D6-44E3-9071-563037B52DA3Q40130043-65A8878C-EDD4-41BA-BE98-F74BE60F7619Q40199804-AB2DC641-3113-4EA5-89CD-8FEFA7A9D95B
P2860
Effects of upper respiratory tract infections in patients with cystic fibrosis.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@ast
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@en
type
label
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@ast
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@en
prefLabel
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@ast
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@en
P2093
P2860
P356
P1433
P1476
Effects of upper respiratory tract infections in patients with cystic fibrosis.
@en
P2093
Collinson J
Hammersley V
Ireland DC
Nicholson KG
O'Callaghan C
P2860
P304
P356
10.1136/THX.51.11.1115
P407
P577
1996-11-01T00:00:00Z